SE0303050L - Dosmombinationer - Google Patents
DosmombinationerInfo
- Publication number
- SE0303050L SE0303050L SE0303050A SE0303050A SE0303050L SE 0303050 L SE0303050 L SE 0303050L SE 0303050 A SE0303050 A SE 0303050A SE 0303050 A SE0303050 A SE 0303050A SE 0303050 L SE0303050 L SE 0303050L
- Authority
- SE
- Sweden
- Prior art keywords
- doses
- entities
- combined doses
- medicaments
- powder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0303050A SE527190C2 (sv) | 2003-06-19 | 2003-11-17 | Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid |
US10/870,907 US20050042174A1 (en) | 2003-06-19 | 2004-06-21 | Combined doses |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301816A SE526850C2 (sv) | 2003-06-19 | 2003-06-19 | Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd |
US50026203P | 2003-09-05 | 2003-09-05 | |
SE0303050A SE527190C2 (sv) | 2003-06-19 | 2003-11-17 | Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid |
Publications (3)
Publication Number | Publication Date |
---|---|
SE0303050D0 SE0303050D0 (sv) | 2003-11-17 |
SE0303050L true SE0303050L (sv) | 2004-12-20 |
SE527190C2 SE527190C2 (sv) | 2006-01-17 |
Family
ID=29740584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0303050A SE527190C2 (sv) | 2003-06-19 | 2003-11-17 | Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid |
Country Status (2)
Country | Link |
---|---|
US (1) | US20050042174A1 (sv) |
SE (1) | SE527190C2 (sv) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE526850C2 (sv) * | 2003-06-19 | 2005-11-08 | Microdrug Ag | Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd |
SE526509C2 (sv) * | 2003-06-19 | 2005-09-27 | Microdrug Ag | Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd |
SE527069C2 (sv) * | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
SE527200C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av formaterol och fluticason |
CA2653105A1 (en) * | 2006-05-24 | 2007-11-29 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
BRPI1011229B8 (pt) * | 2009-05-29 | 2021-05-25 | Pearl Therapeutics Inc | co-suspensão dispensável a partir de um inalador de dose medida compreendendo propelente, partículas de agente ativo e partículas em suspensão |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
TR200907238A2 (tr) * | 2009-09-23 | 2011-04-21 | Bi̇lgi̇ç Mahmut | Tiotropyum içeren kombinasyonun blisterde taşınması. |
TR200907236A2 (tr) * | 2009-09-23 | 2011-04-21 | Bi̇lgi̇ç Mahmut | Tiotropyum kuru toz formülasyonunun blister ambalajda taşınması. |
US20130064870A1 (en) * | 2010-05-20 | 2013-03-14 | Sun Pharma Advanced Research Company Limited | Dry powder inhalation composition |
KR20180091120A (ko) | 2010-07-16 | 2018-08-14 | 시플라 리미티드 | R (+) 부데소나이드 및 1종 이상의 기관지확장제를 포함하는 약학 조성물 |
WO2012010854A1 (en) | 2010-07-23 | 2012-01-26 | Cipla Limited | Inhalation formulations comprising carmoterol in combination with a corticosteroid |
WO2012049444A1 (en) | 2010-10-12 | 2012-04-19 | Cipla Limited | Pharmaceutical composition |
EP2749283A3 (en) | 2011-02-17 | 2014-08-20 | Cipla Limited | Combination of glycopyrronium and olodaterol |
EA201490991A1 (ru) * | 2011-05-17 | 2014-09-30 | Перл Терапьютикс, Инк. | Композиции, способы и устройства для респираторной доставки двух или более активных средств |
KR20130140358A (ko) | 2012-06-14 | 2013-12-24 | 한미약품 주식회사 | 살메테롤 지나포산염, 플루티카손 프로피오네이트 및 티오트로피움 브로마이드를 포함하는 흡입 제형용 건조 분말 및 이의 제조방법 |
BR112015022784B1 (pt) | 2013-03-15 | 2023-02-14 | Pearl Therapeutics, Inc | Método de condicionamento de material cristalino micronizado e sistemas de condicionamento |
WO2021216710A1 (en) * | 2020-04-24 | 2021-10-28 | The Medical College Of Wisconsin, Inc. | Use of salmeterol as an anti-coronaviral agent |
WO2021260437A1 (en) * | 2020-06-26 | 2021-12-30 | Mylan Pharma Uk Limited | Multi-layered medicament for inhalation |
WO2021260441A1 (en) * | 2020-06-26 | 2021-12-30 | Mylan Pharma Uk Limited | Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
US6536427B2 (en) * | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
HU0004452D0 (sv) * | 1991-12-18 | 2001-01-29 | Astra Ab | |
US5437267A (en) * | 1993-08-03 | 1995-08-01 | Weinstein; Allan | Device for delivering aerosol to the nasal membranes and method of use |
DE19541594A1 (de) * | 1995-11-08 | 1997-05-15 | Pfeiffer Erich Gmbh & Co Kg | Austrag-Einheit für Medien |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
ATE382386T1 (de) * | 1998-11-13 | 2008-01-15 | Jagotec Ag | Multidosis-trockenpulverinhalator mit pulverreservoir |
DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
US6369115B1 (en) * | 2000-03-20 | 2002-04-09 | Dura Pharmaceuticals, Inc. | Stabilized powder formulations |
GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
SE517229C2 (sv) * | 2000-09-25 | 2002-05-14 | Microdrug Ag | Kontinuerlig inhalator för torrt pulver |
US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
SE527200C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av formaterol och fluticason |
SE526850C2 (sv) * | 2003-06-19 | 2005-11-08 | Microdrug Ag | Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd |
-
2003
- 2003-11-17 SE SE0303050A patent/SE527190C2/sv not_active IP Right Cessation
-
2004
- 2004-06-21 US US10/870,907 patent/US20050042174A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SE0303050D0 (sv) | 2003-11-17 |
SE527190C2 (sv) | 2006-01-17 |
US20050042174A1 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0303050L (sv) | Dosmombinationer | |
JP4497730B2 (ja) | 複合薬剤用の粉末吸入器 | |
KR20090005379A (ko) | 간소형 흡입기 | |
JP2002541990A (ja) | 複合薬剤用の粉末吸入器 | |
SE0302939D0 (sv) | Combined doses of formoterol and fluticasone | |
US7431916B2 (en) | Administration of medicinal dry powders | |
SE0303128D0 (sv) | Combined doses of formoterol and an anticholinergic agent | |
SE0303091D0 (sv) | Combined doses of tiotropium andfluticasone | |
JP7010978B2 (ja) | 乾燥粉末吸入器 | |
SE0303375D0 (sv) | Combined doses of formoterol and budesonide | |
CA3140088A1 (en) | Electronically supervised administration of a pharmaceutical composition | |
SE0301816D0 (sv) | Combined doses | |
JP2004523536A5 (sv) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |